Abstract
A liquid chromatograpy-nanoelectrospray ionization-high resolution tandem mass spectrometry (LC–NSI–HRMS/MS) method was developed for quantitation of the DNA adducts 7-(2′-carboxyethyl)guanine (7-2′-CEG) and N2-(1′-carboxyethyl)guanine (N2-1′-CEG), as their methyl esters, in human leukocyte DNA from smokers and non-smokers. 7-2′-CEG has been previously identified in all human liver samples analyzed and is formed from an unknown carboxyethylating agent while N2-1′-CEG is formed from the advanced glycation endproduct methyl glyoxal. The method was applied for the analysis of these two DNA adducts in leukocyte DNA from 20 smokers and 20 non-smokers, in part to test the hypothesis that 7-2′-CEG could be formed by endogenous nitrosation, as previously observed in rats treated with nitrosodihydrouracil and nitrite. Levels of 7-2′-CEG (mean ± S.D.) were 0.6 ± 0.2 pmol/μmol dG in smokers and 0.5 ± 0.2 pmol/μmol dG in non-smokers, while those of N2-1′-CEG were 4.5 ± 1.9 pmol/μmol dG in smokers and 4.6 ± 2 pmol/μmol dG in non-smokers. These results did not support our hypothesis that endogenous nitrosation of dihydrouracil in smokers leads to higher levels of 7-2′-CEG in leukocyte DNA than in non-smokers. However the study provides the first data on levels of these DNA adducts in human leukocyte DNA, and the LC–NSI–HRMS/MS method developed for their quantitation could be important for future studies of DNA damage by methyl glyoxal.
Original language | English (US) |
---|---|
Article number | 109140 |
Journal | Chemico-Biological Interactions |
Volume | 327 |
DOIs | |
State | Published - Aug 25 2020 |
Bibliographical note
Funding Information:This study was supported by grants CA-138338 from the U.S. National Cancer Institute and CA-203851 and N01 PC-064402 from the U.S. National Cancer Institute and Food and Drug Administration Center for Tobacco Products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, University of Minnesota , supported in part by Cancer Center Support Grant CA-077598 .
Funding Information:
This study was supported by grants CA-138338 from the U.S. National Cancer Institute and CA-203851 and N01 PC-064402 from the U.S. National Cancer Institute and Food and Drug Administration Center for Tobacco Products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, University of Minnesota, supported in part by Cancer Center Support Grant CA-077598.
Publisher Copyright:
© 2020 Elsevier B.V.
Keywords
- 7-(2′-carboxyethyl)guanine
- Advanced glycation end products
- Endogenous nitrosation
- Liquid chromatograpy-nanoelectrospray ionization-high resolution tandem mass spectrometry
- Methyl glyoxal
- N-(1′-carboxyethyl)guanine